These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3297156)

  • 1. Manipulation of the intratumor infiltrate by anti-tumor antibody conjugates.
    Obrist R
    Biochim Biophys Acta; 1987 Jul; 907(2):175-90. PubMed ID: 3297156
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotactic anti-tumor antibodies: in vitro results with four different antibody preparations.
    Obrist R; Obrecht JP; Bast RC; Sandberg AL
    Adv Exp Med Biol; 1985; 186():827-32. PubMed ID: 4050600
    [No Abstract]   [Full Text] [Related]  

  • 3. Human macrophages armed with murine immunoglobulin G2a antibodies to tumors destroy human cancer cells.
    Steplewski Z; Lubeck MD; Koprowski H
    Science; 1983 Aug; 221(4613):865-7. PubMed ID: 6879183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The preclinical screening laboratory: evaluation of immunomodulatory and therapeutic properties of biological response modifiers.
    Talmadge JE; Herberman RB
    Cancer Treat Rep; 1986 Jan; 70(1):171-82. PubMed ID: 3510733
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunological stimulation in situ: the acute and chronic inflammatory responses in the induction of tumor immunity.
    Hanna MG; Bucana CD; Pollack VA
    Contemp Top Immunobiol; 1980; 10():267-96. PubMed ID: 6996910
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhancement of macrophage invasion of tumors by administration of chemotactic factor-antitumor antibody conjugates.
    Obrist R; Sandberg AL
    Cell Immunol; 1983 Oct; 81(1):169-74. PubMed ID: 6651932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated macrophages and the antitumor action of BCG.
    Alexander P
    Natl Cancer Inst Monogr; 1973 Dec; 39():127-33. PubMed ID: 4595313
    [No Abstract]   [Full Text] [Related]  

  • 8. IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells.
    Herlyn D; Koprowski H
    Proc Natl Acad Sci U S A; 1982 Aug; 79(15):4761-5. PubMed ID: 6289317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Activation of cellular immunity in mice under normal conditions and in tumor growth during treatment with glucosaminyl muramyl dipeptide].
    Pimenov AA; Rakhmilevich AL; Deev VV; Kirillova IV; Migdal TL; Andronova TM; Fuks BB
    Vopr Med Khim; 1990; 36(1):58-60. PubMed ID: 2343578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deactivation of guinea pig pulmonary alveolar macrophage responses to N-formyl-methionyl-leucyl-phenylalanine: chemotaxis, superoxide generation, and binding.
    Daughaday CC; Mehta J; Spilberg I; Atkinson JP
    J Immunol; 1985 Mar; 134(3):1823-6. PubMed ID: 2981922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of chemokines and formyl peptides in pneumococcal pneumonia-induced monocyte/macrophage recruitment.
    Fillion I; Ouellet N; Simard M; Bergeron Y; Sato S; Bergeron MG
    J Immunol; 2001 Jun; 166(12):7353-61. PubMed ID: 11390486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
    Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
    J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A review on mechanism of anti-tumor action of BCG (author's transl)].
    Tokunaga T
    Kekkaku; 1980 Aug; 55(8):351-7. PubMed ID: 6999202
    [No Abstract]   [Full Text] [Related]  

  • 14. [Histopathological aspects and macrophage reactivity in rats with Guerin's T8 viral tumor after treatment with Corynebacterium parvum].
    Caruso R; Bonina L; Chimicata S; Iannello D; Inferrera C; Mastroeni P
    Arch De Vecchi Anat Patol; 1979 Mar; 63(3):491-9. PubMed ID: 262125
    [No Abstract]   [Full Text] [Related]  

  • 15. Liposome-encapsulated macrophage activation agents and active non-specific immunotherapy of neoplastic disease.
    Poste G; Kirsh R
    Prog Clin Biol Res; 1982; 102 pt A():309-19. PubMed ID: 7167443
    [No Abstract]   [Full Text] [Related]  

  • 16. Critical review of previously reported animal studies of tumor immunotherapy with nonspecific immunostimulants.
    Bast RC; Bast BS
    Ann N Y Acad Sci; 1976; 277(00):60-93. PubMed ID: 826208
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunomodulation and antitumor effects of MVE-2 in mice.
    Talmadge JE; Maluish AE; Collins M; Schneider M; Herberman RB; Oldham RK; Wiltrout RH
    J Biol Response Mod; 1984 Dec; 3(6):634-52. PubMed ID: 6334720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy of guinea pig cancer with BCG.
    Zbar B
    Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
    [No Abstract]   [Full Text] [Related]  

  • 19. Assay for macrophage-mediated anti-tumor cytotoxicity.
    Cox GW
    Curr Protoc Immunol; 2001 May; Chapter 14():Unit 14.7. PubMed ID: 18432725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-dependent macrophage-mediated cytolysis in a murine syngeneic tumor system.
    Yamazaki M; Shinoda H; Mizuno D
    Gan; 1976 Oct; 67(5):651-60. PubMed ID: 1017582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.